New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.
about
Construction of microRNA and transcription factor regulatory network based on gene expression data in cardiomyopathyLoss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammalsStudy of bovine gene: the temporal-spatial expression patterns, polymorphism and association analysis with meat production traits.
P2860
New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@en
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@nl
type
label
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@en
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@nl
prefLabel
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@en
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@nl
P2093
P2860
P1476
New polymorphisms in human MEF ...... f hypertrophic cardiomyopathy.
@en
P2093
Cristina Alonso-Montes
Eliecer Coto
Isabel Rodriguez
Jose Luis Fernandez-Martin
Julian Rodriguez-Reguero
Manuel Naves-Diaz
P2860
P2888
P304
P356
10.1007/S11033-012-1740-7
P577
2012-06-21T00:00:00Z